Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: To explore attitudes about artificial intelligence (AI) among staff who utilized AI-based clinical decision support (CDS).

Methods: A survey was designed to assess staff attitudes about AI-based CDS tools. The survey was anonymously and voluntarily completed by clinical staff in three primary care outpatient clinics before and after implementation of an AI-based CDS system aimed to improve glycemic control in patients with diabetes as part of a quality improvement project. The CDS identified patients at risk for poor glycemic control and generated intervention recommendations intended to reduce patients' risk.

Results: Staff completed 45 surveys pre-intervention and 38 post-intervention. Following implementation, staff felt that care was better coordinated (11 favorable responses, 14 unfavorable responses pre-intervention; 21 favorable responses, 3 unfavorable responses post-intervention; p < 0.01). However, only 14 % of users would recommend the AI-based CDS. Staff feedback revealed that the most favorable aspect of the CDS was that it promoted team dialog about patient needs (N = 14, 52 %), and the least favorable aspect was inadequacy of the interventions recommended by the CDS.

Conclusions: AI-based CDS tools that are perceived negatively by staff may reduce staff excitement about AI technology, and hands-on experience with AI may lead to more realistic expectations about the technology's capabilities. In our setting, although AI-based CDS prompted an interdisciplinary discussion about the needs of patients at high risk for poor glycemic control, the interventions recommended by the CDS were often perceived to be poorly tailored, inappropriate, or not useful. Developers should carefully consider tasks that are best performed by AI and those best performed by the patient's care team.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijmedinf.2019.104072DOI Listing

Publication Analysis

Top Keywords

ai-based cds
20
glycemic control
12
clinical decision
8
decision support
8
staff
8
cds
8
cds tools
8
risk poor
8
poor glycemic
8
favorable responses
8

Similar Publications

Purpose: AI-based clinical decision support (CDS) is hailed as the solution to many healthcare capacity problems. However, there is a known implementation gap in AI CDS. Studies exploring barriers and enablers rely on abstract definitions or participants' understanding of AI.

View Article and Find Full Text PDF

This study explores Chinese physicians' perspectives on the integration of clinical decision support (CDS) into electronic health records for COVID-19 management. A total of 148 physicians were surveyed, of whom 98.6% (146/148) completed the questionnaire.

View Article and Find Full Text PDF

This review focuses on integrating artificial intelligence (AI) into healthcare, particularly for predicting adverse events, which holds potential in clinical decision support (CDS) but also presents significant challenges. Biases in data acquisition, such as population shifts and data scarcity, threaten the generalizability of AI-based CDS algorithms across different healthcare centers. Techniques like resampling and data augmentation are crucial for addressing biases, along with external validation to mitigate population bias.

View Article and Find Full Text PDF

Objective: Artificial intelligence (AI)-based clinical decision support (CDS) has the potential to augment high-stakes clinical decisions in the emergency department (ED). However, its current usage and translation to implementation remains poorly understood. We asked: (1) What is the current landscape of AI-CDS for individual patient care in the ED? and (2) What phases of development have AI-CDS tools achieved?

Methods: We performed a scoping review of AI for prognostic, diagnostic, and treatment decisions regarding individual ED patient care.

View Article and Find Full Text PDF

Colorectal cancer is the second most common cause of cancer-related deaths worldwide and the third most common cancer overall. In this study, we investigate the anti-colon cancer potential of phytochemically, and thermally synthesised novel green carbon dots based on Rhododendron luteum (RL-CDs). A new synthesis method was used to produce carbon dots obtained from the Rhododendron luteum (RL) plant in an environmentally friendly manner.

View Article and Find Full Text PDF